Department of Clinical Neuroscience, School of Medicine, University of Cambridge, Cambridge, UK
Joanne L Jones*Department of Clinical Neuroscience, School of Medicine, University of Cambridge, Cambridge, UK
Patrick VermerschUniv. Lille, INSERM UMR-S1172—Lille Neuroscience et Cognition, CHU Lille, FHU Precise, Lille, France
Ann D BassNeurology Center of San Antonio, San Antonio, TX, USA
Andrew ChanBern University Hospital and University of Bern, Bern, Switzerland
Óscar FernándezFundacion IMABIS, Hospital Universitario Carlos Haya, Málaga, Spain
Gavin GiovannoniBarts and The London School of Medicine, Queen Mary University of London, London, UK
Eva Kubala HavrdovaDepartment of Neurology, First Medical Faculty, Charles University, Prague, Czech Republic
Xavier MontalbanDepartment of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain
Celia Oreja-GuevaraDepartment of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain/Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain
Fredrik PiehlNeuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Tjalf ZiemssenCenter of Clinical Neuroscience, Department of Neurology Carl Gustav Carus University Hospital, Dresden University of Technology, Dresden, Germany
on behalf of the CAMMS223, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigatorsAJ Coles Department of Clinical Neuroscience, School of Medicine, University of Cambridge, Box 165, Level 5 Block A, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK. [email protected]
*Co-first authors.
Comments (0)